LLY
2024Q1BMOEli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS2.49
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.1%
IV front—
P/C full—
P/C front—
Features as of2024-04-29
Run-up
Close—
Ret 5d+0.8%
Ret 10d-1.8%
Ret 20d-3.1%
Ret 30d-2.3%
Actual EPS
2.58Beat
Estimated EPS2.49
Actual revenue
8.8B
Surprise %+3.6%
Beat / missBeat
Beat streak 44
Beat streak 84
Reaction
1-day stock reaction+0.8%
Implied vs actual
Implied 2.1%Actual 5.1%
Gap reaction+5.1%
Day result+6.0%
Next-day upYes
Realized / IV2.45×
Post tape
Post 5d-0.4%
Post 10d-2.2%
Post volume7.4M
Vol ×10d3.01×
Vol ×20d3.17×
Post range3.6%